Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Kardiol Pol ; 82(5): 516-526, 2024.
Article in English | MEDLINE | ID: mdl-38606742

ABSTRACT

BACKGROUND: Knowledge of thrombosis (T) risk predictors and transesophageal echocardiography (TEE) are important tools in appropriate qualification of patients for safe electrical cardioversion. AIMS: We aimed to investigate predictors of T and spontaneous echocardiographic contrast (SEC) with sludge in the left atrium (LA) and appendage (LAA) in atrial fibrillation (AF) patients on oral anticoagulation. METHODS: The study included 300 patients with AF lasting >48 hours. Two hundred and nineteen patients were treated with oral anticoagulants (OACs) (study group, rivaroxaban: 104 [47.5%], apixaban: 52 [23.7%], dabigatran: 23 [11.5%], VKAs: 40 [18.3%]). Eighty-one consecutive patients with AF lasting >48 hours and not treated with OACs constituted the control group. Before electrical cardioversion, all patients underwent transthoracic echocardiography and TEE. RESULTS: TEE revealed T in the LAA in 4.7% of cases. The number of patients with T or SEC4+ with sludge in the OAC and control groups was similar, 5.9% vs. 1.2% and 16.4% vs. 16.0%, respectively. The risk of SEC4+/T in patients treated with OACs was lowest in those taking rivaroxaban (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.21-0.87; P = 0.027) and highest in those receiving VKAs (OR, 2.49; 95% CI, 1.15-5.39; P = 0.018). Multivariable analysis showed independent prognostic factors for SEC 4+/T: female sex (OR, 3.800; 95% CI, 1.592-9.072; P = 0.003), left ventricular ejection fraction (OR, 0.932; 95% CI, 0.890-0.957; P <0.001), and minimum LAA flow velocity (LAAfly min) (OR, 0.895; 95% CI, 0.841-0.954; P <0.001). CONCLUSIONS: Female sex, transthoracic echocardiography, and TEE results should be taken into account in assessing the risk of T/SEC with sludge in LA/LAA patients with AF.


Subject(s)
Anticoagulants , Atrial Fibrillation , Echocardiography, Transesophageal , Electric Countershock , Thrombosis , Humans , Atrial Fibrillation/complications , Female , Male , Aged , Middle Aged , Anticoagulants/therapeutic use , Anticoagulants/administration & dosage , Risk Factors , Thrombosis/etiology , Thrombosis/prevention & control , Administration, Oral , Rivaroxaban/therapeutic use , Rivaroxaban/administration & dosage , Echocardiography , Heart Atria/diagnostic imaging , Pyridones/therapeutic use , Pyridones/administration & dosage , Pyrazoles/therapeutic use , Pyrazoles/administration & dosage , Dabigatran/therapeutic use , Dabigatran/administration & dosage
3.
Pacing Clin Electrophysiol ; 39(1): 28-35, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26412411

ABSTRACT

BACKGROUND: Sexual dysfunctions, especially erectile dysfunction (ED), are a major problem in cardiovascular patients. They are caused by cardiovascular risk factors including low-grade inflammation process, endothelial dysfunction, oxidative stress, and hemodynamic and vascular alterations. The same mechanisms are some of the main causes and/or consequences of atrial fibrillation (AF). To this day, literature provides no cross-sectional data on the prevalence of sexual dysfunction in AF. The study aimed to determine the prevalence of sexual dysfunction in consecutive, young male patients with AF. MATERIAL AND METHODS: A cross-sectional survey of adult male patients with a primary diagnosis of AF was conducted at University Cardiology Departments, during the period of July 2013 to July 2014. During the enrollment process, the study participants were either electively hospitalized with a primary diagnosis of AF, or had a scheduled outpatient visit. Sexual dysfunctions were assessed using the International Index of Erectile Function. RESULTS: A total of 129 consecutive AF patients (mean age 57.0 ± 11.8 years) were analyzed. Hypertension was present in 60.5%, diabetes in 22.5% of patients, 46.5% had dyslipidemia, 18.6% were current smokers, and 45.7% had a family history of cardiovascular disease. At least one kind of sexual dysfunction was found in 86.8% of patients. ED was present in 57.4% of patients, 44.2% of patients had orgasmic dysfunction, 69.0% had lowered sexual desire, 65.1% had lowered intercourse satisfaction, and 55.8% had lowered overall satisfaction. CONCLUSIONS: Sexual dysfunctions are highly prevalent in AF patients and are not only limited to ED, but also include dysfunction of orgasmic function, desire, or general satisfaction. In part, the presence of the sexual dysfunctions is probably caused by classical cardiovascular risk factors highly prevalent in AF patients, but the impact of AF itself cannot be underestimated.


Subject(s)
Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Erectile Dysfunction/diagnosis , Erectile Dysfunction/epidemiology , Orgasm , Adult , Age Distribution , Aged , Causality , Comorbidity , Cross-Sectional Studies , Humans , Male , Middle Aged , Poland/epidemiology , Prevalence , Risk Factors , Young Adult
4.
Kardiochir Torakochirurgia Pol ; 12(3): 251-4, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26702284

ABSTRACT

We present a case report of a 60-year-old woman with a long history of leiomyosarcoma in different locations. She was admitted to the clinic due to a left ventricular tumor diagnosed in ECHO examination. The patient was qualified for radical tumor resection. The early postoperative period was complicated due to low cardiac output syndrome and bradyarrhythmia requiring temporary cardiac pacing. Optimized pharmacological therapy resulted in a gradual reduction of symptoms and a clinical improvement of congestive heart failure (NYHA III - NYHA II). Due to the radical nature of the surgery, the patient was not referred for supplementary treatment. The follow-up currently exceeds 12 months - no new metastases have been found. This case provides an example of how to diagnose and treat heart tumors.

6.
J Thromb Thrombolysis ; 40(2): 240-7, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25490871

ABSTRACT

Assessment of thromboembolic risk is crucial for proper management of atrial fibrillation (AF) patients. Currently used risk score base only on scarce clinical data and do not take into consideration parameters including echocardiographic findings. The aim of this study was to evaluate if left atrium (LA) enlargement is associated with higher thromboembolic risk assessed by CHADS2 and CHA2DS2-VASc scores in a cohort of unselected non-valvular AF patients. Data from 582 AF hospitalizations occurring between November 2012 and January 2014 were analyzed. All patients underwent a standard transthoracic echocardiography and had their thromboembolic risk assessed in both CHADS2 and CHA2DS2-VASc scores. In 494 enrolled patients (48.5 % male; mean age 73.4 ± 11.5 years) AF was classified as paroxysmal in 233 (47.3 %), as persistent in 109 (22.1 %), and as permanent in 151 (30.6 %) patients. LA was enlarged in 426 (86.2 %) patients. Enlargement was classified as mild in 99 (20.0 %) patients, as moderate in 130 (26.3 %) patients, and as severe in 196 (39.7 %) patients. Patients with enlarged LA had higher mean CHADS2 score (2.0 ± 1.5 vs. 2.6 ± 1.3; p = 0.0005) and CHA2DS2-VASc (3.8 ± 2.0 vs. 4.4 ± 1.8; p = 0.02) score than patients with normal LA. The both mean scores rose along with rising LA diameter. LA enlargement is highly prevalent in AF patients. Higher thromboembolic risk assessed by both CHADS2 and CHA2DS2-VASc scores is associated with presence of LA enlargement. Echocardiographically assessed LA size may be an additional parameter useful in thromboembolic risk stratification of AF patients.


Subject(s)
Atrial Fibrillation/complications , Atrial Fibrillation/physiopathology , Electrocardiography , Thromboembolism/etiology , Thromboembolism/physiopathology , Aged , Aged, 80 and over , Female , Heart Atria/physiopathology , Humans , Male , Middle Aged , Risk Factors
8.
Kardiol Pol ; 71(7): 741-3, 2013.
Article in Polish | MEDLINE | ID: mdl-23907909

ABSTRACT

Peripartum cardiomyopathy is a type of dilatated cardiomyopathy, occuring with symptoms of heart failure (HF) during last month of pregnancy or within 5 months after labour. Authors are presenting the case of patient admitted to hospital primary with diagnosis of non-high risk pulmonary embolism 6 weeks after delivery, who developed episode of sudden cardiac death followed by symptoms of cardiogenic shock. Peripartum cardiomyopathy was additionally diagnosed. After HF treatment with bromocriptine supply, gradual clinical improvement was achieved. The patient was discharged after 15 days of hospitalisation with diagnosis of peripartum cardiomyopathy with non-high risk pulmonary embolism.


Subject(s)
Bromocriptine/therapeutic use , Death, Sudden, Cardiac , Dopamine Agonists/therapeutic use , Pregnancy Complications, Cardiovascular/drug therapy , Puerperal Disorders/drug therapy , Pulmonary Embolism/drug therapy , Adult , Dyspnea/etiology , Female , Humans , Peripartum Period , Pregnancy , Time Factors , Treatment Outcome
9.
Kardiol Pol ; 66(10): 1083-6, 2008 Oct.
Article in Polish | MEDLINE | ID: mdl-19006030

ABSTRACT

A 25-year-old woman, gravida 2, para 1, without any previous medical history was admitted to the hospital because of the signs and symptoms of fetal distress. After a caesarean section the woman developed an acute heart failure. Echocardiography demonstrated massive vegetations attached to aortic and mitral valves with their destruction. Surgical treatment was performed immediately. The postoperative period was complicated by chronic atrioventricular third degree heart block, requiring implantation of a pacemaker. Finally the woman was discharged from hospital and is followed regularly in the out-patient cardiac clinic.


Subject(s)
Endocarditis, Bacterial/therapy , Heart Failure/microbiology , Mitral Valve Insufficiency/therapy , Pregnancy Complications, Cardiovascular/therapy , Pregnancy Complications, Infectious/therapy , Acute Disease , Adult , Endocarditis, Bacterial/complications , Female , Heart Failure/therapy , Humans , Infant, Newborn , Mitral Valve Insufficiency/microbiology , Pacemaker, Artificial , Pregnancy , Pregnancy Complications, Cardiovascular/microbiology , Pregnancy Complications, Infectious/microbiology , Treatment Outcome
10.
Kardiol Pol ; 66(9): 969-71, 2008 Sep.
Article in Polish | MEDLINE | ID: mdl-18924025

ABSTRACT

Deep upper limbs veins thrombosis is a relatively rare condition in comparison to the lower limbs thrombosis. Most commonly occurs as a complication of major veins catheterisation. It may also be caused by stenosis of axillar or subclavian veins due to neoplastic infiltration, enlarged lymph nodes or congenital thrombophilia. The Paget-von Schrötter syndrome caused by exercise-induced thrombosis described in this case report is very infrequent.


Subject(s)
Pulmonary Embolism/diagnostic imaging , Subclavian Vein , Upper Extremity/diagnostic imaging , Venous Thrombosis/diagnosis , Anticoagulants/administration & dosage , Constriction, Pathologic , Female , Humans , Phlebography , Pulmonary Embolism/drug therapy , Pulmonary Embolism/etiology , Syndrome , Treatment Outcome , Venous Thrombosis/complications , Venous Thrombosis/drug therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...